Simultaneous administration of antithrombin III and protein C concentrates for the treatment of a devastating coagulopathy in a child

Hematology and Cell Therapy

Volumn 40, Issue 2, 1998, Pages 67-70

  Favier, R ^a   Deschamps, A ^b   Belhocine, R ^c   Ankri, A ^c   Costil, J ^a   De Moerloose, P ^d  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b HÔPITAL ROTHSCHILD   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Antithrombin; Disseminated intravascular coagulation; Pediatrics; Protein C; Prothrombin fragments F1+2

Indexed keywords

AMIKACIN; ANTITHROMBIN III; CEFOTAXIME; FIBRINOGEN; FRESH FROZEN PLASMA; HEPARIN; PROTEIN C;

ARTICLE; CASE REPORT; CHILD; DISSEMINATED INTRAVASCULAR CLOTTING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; THROMBOCYTE TRANSFUSION;

ANTITHROMBIN III; CHILD; DISSEMINATED INTRAVASCULAR COAGULATION; DRUG THERAPY, COMBINATION; HEMOSTASIS; HUMANS; MALE; PROTEIN C;

EID: 0031979121     PISSN: 12693286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Andrew M, Brooker L, Mitchell L (1994) Acquired antithrombin III deficiency secondary to asparaginase therapy in childhood acute lymphoblastic leukaemia. Blood Coagul Fibrinolysis 5: S24-S36
2. Asakzura H, Shiraton Y, Saito M, et al. (1993) Changes in plasma levels of prothrombin fragments F1+2 in cases of disseminated intravascular coagulation. Acta Haematol 89: 22-25
3. Dreyfus M, Magny JF, Bridey F, et al. (1991) Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 325: 1565-1568
4. Emerson TE (1994) Antithrombin III replacement in animal models of acquired antithrombin III deficiency. Blood Coagul Fibrinolysis 5: S37-S45
5. Fourier F, Chopin C, Huarte J, et al. (1993) Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 104: 882-888
6. Gerson WT, Dickerman JD, Bovill EG, et al. (1993) Severe acquired protein C deficiency in purpura fulminans associated with disseminated intravascular coagulation: treatment with protein C concentrate. Pediatrics 91: 418-422
7. Hanada T, Abe T, Takita H (1985) Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children. Am J Pediatr Hematol 7: 3-8
8. Kessler CM, Tang ZC, Jacobs HM, et al. (1997) The supraphysiologic dosing of antithrombin concentrate for Staphylococcus Aureus-induced disseminated intravascular coagulation in guinea pigs: substantial reduction in mortality and morbidity. Blood 89: 4393-4401
9. Lechner K, Kyrle PA (1995) Antithrombin III concentrates: are they clinically useful? Thromb Haemost 73: 340-348
10. Okajima K, Imamura H, Koga S, et al. (1990) Treatment of patients with disseminated intravascular coagulation by protein C. Am J Hematol 33: 277-278
11. Rintala E, Seppälä OP, Kotilainen P, et al. (1996) Protein C in the treatment of coagulopathy in meningococcal disease (letter). Lancet 347: 1767
12. Rivard GE, David M, Farrell C, et al. (1995) Treatment of purpura fulminans in meningococcemia with protein C concentrates. J Pediatr 126: 646-652
13. Taylor FB, Chang A, Esmon CT, et al. (1987) Protein C prevents the coagulopathic and lethal effects of Escherichia Coli infusion in the baboon. J Clin Invest 79: 918-925
14. Taylor FB, Chang A, Peer GT, et al. (1991) DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia Coli without preventing shock or organ damage. Blood 78: 364-368
15. Von Kries R, Stannigel H, Gobel U (1985) Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation. Eur J Pediatr 144: 191-194
16. Yamauchi T, Umeda F, Inoguchi T, et al. (1989) Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Biochem Biophys Res Commun 163: 1404-1411